Publications
Detailed Information
The sequencing of chemotherapy and radiotherapy in breast cancer patients after mastectomy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Hak Jae | - |
dc.contributor.author | Kim, Jae-Sung | - |
dc.contributor.author | Chie, Eui Kyu | - |
dc.contributor.author | Noh, Dong-young | - |
dc.contributor.author | Ha, Sung Whan | - |
dc.contributor.author | Bang, Yung-jue | - |
dc.date.accessioned | 2012-06-25T05:47:57Z | - |
dc.date.available | 2012-06-25T05:47:57Z | - |
dc.date.issued | 2010-02 | - |
dc.identifier.citation | TUMORI; Vol.96 1; 28-33 | ko_KR |
dc.identifier.issn | 0300-8916 | - |
dc.identifier.uri | https://hdl.handle.net/10371/77391 | - |
dc.description.abstract | Background. The purpose of the study was to retrospectively evaluate the outcome according to the sequencing of radiotherapy and chemotherapy after mastectomy in high-risk patients with breast cancer. Methods. From January 1986 through September 2000, 275 women with stage I-IIIB breast cancer were treated with chemotherapy and radiotherapy after mastectomy The patients were divided into four groups. Chemotherapy was given first in 116 patients (CTRT), concurrent chemoradiotherapy in 77 (CCRT), sandwich therapy in 65 (SAND), and radiotherapy first in 17 (RTCT). Prognostic factors such as age, primary tumor size and nodal status were not statistically different among the four groups. There was a higher proportion of patients with close or positive margins in CCRT and RTCT groups than in the CTRT and SAND groups (22/77, 5/17 vs 3/116, 2/65, P<0.001). Results. Median follow-up was 145 months (range, 10-210). Five-year overall and disease-free survival were 69.4% and 56.1%, respectively Survival outcomes were not statistically different among the four groups (5-year overall/disease-free survival, 68.0%/63.0%, 71.3%/60.8%, 65.0%/48.1%, 81.9%/58.8%, in CTRT, CCRT, SAND, and RTCT, respectively) (P = 0.3422/P = 0.6333). The incidence of local-regional recurrence was not different in the early radiotherapy group (CCRT/RICT, 11%/12%) and delayed radiotherapy group (CTRT/SAND, 7%/8%). Conclusions. This study suggests that in these high-risk breast cancer patients after mastectomy, delay in the start of radiotherapy does not increase local-regional recurrence, and the final survival outcomes are not affected by the sequencing of chemotherapy and radiotherapy. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | PENSIERO SCIENTIFICO EDITOR | ko_KR |
dc.subject | breast cancer | ko_KR |
dc.subject | sequence | ko_KR |
dc.subject | chemotherapy | ko_KR |
dc.subject | radiotherapy | ko_KR |
dc.title | The sequencing of chemotherapy and radiotherapy in breast cancer patients after mastectomy | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 김학재 | - |
dc.contributor.AlternativeAuthor | 김재성 | - |
dc.contributor.AlternativeAuthor | 지의규 | - |
dc.contributor.AlternativeAuthor | 노동영 | - |
dc.contributor.AlternativeAuthor | 방영주 | - |
dc.contributor.AlternativeAuthor | 하성환 | - |
dc.citation.journaltitle | TUMORI | - |
dc.description.citedreference | Piroth MD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-114 | - |
dc.description.citedreference | Goldhirsch A, 2005, ANN ONCOL, V16, P1569, DOI 10.1093/annonc/mdi326 | - |
dc.description.citedreference | BELTON JR, 2005, CLIN ONCOL, V23, P1934 | - |
dc.description.citedreference | White J, 2004, INT J RADIAT ONCOL, V60, P77, DOI 10.1016/j.ijrobp.2004.02.035 | - |
dc.description.citedreference | RECHT A, 2003, CLIN BREAST CANCER, V11, P4 | - |
dc.description.citedreference | Hebert-Croteau N, 2002, BREAST CANCER RES TR, V74, P77 | - |
dc.description.citedreference | CALAIS G, 2002, INT J RADIAT ONCOL, V54, P57 | - |
dc.description.citedreference | Recht A, 2001, J CLIN ONCOL, V19, P1539 | - |
dc.description.citedreference | Metz JM, 2000, CANCER J, V6, P324 | - |
dc.description.citedreference | Overgaard M, 1997, NEW ENGL J MED, V337, P949 | - |
dc.description.citedreference | Ragaz J, 1997, NEW ENGL J MED, V337, P956 | - |
dc.description.citedreference | Olson JE, 1997, CANCER, V79, P1138 | - |
dc.description.citedreference | Recht A, 1996, NEW ENGL J MED, V334, P1356 | - |
dc.description.citedreference | HARTSELL WF, 1995, CANCER, V76, P2497 | - |
dc.description.citedreference | LEONARD CE, 1995, J CLIN ONCOL, V13, P2906 | - |
dc.description.citedreference | BUZDAR AU, 1993, CANCER, V71, P3680 | - |
dc.description.citedreference | BUCHHOLZ TA, 1993, INT J RADIAT ONCOL, V26, P23 | - |
dc.description.citedreference | GRIEM KL, 1987, J CLIN ONCOL, V5, P1546 | - |
dc.description.tc | 0 | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.